Modified Directly Observed Therapy for Improving Antiretroviral Therapy Adherence in People With HIV

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
HIV Infections
Interventions
BEHAVIORAL

Modified Directly Observed Therapy

Treatment includes storefront modified directly observed therapy (MDOT) of prescribed antiretrovirals. Participants in the MDOT program will report to the study site each morning for 3 months, Monday through Friday, to take their HIV medication and any other medications prescribed by their primary care doctors. At the end of 3 months, participants will no longer attend the study site for medication assistance. Participants will then attend Action Point, a county program that helps participants adhere to taking medication, for an additional 3 months.

BEHAVIORAL

Standard Care

Participants assigned to standard care will report to the study site once a month for 9 months, but will not receive any assistance with taking HIV medications. Information about medication adherence, housing, income, use of health services, drug use, sexual practices, and mental health services will be collected at each visit.

Trial Locations (1)

94102

UCSF Market Street Study Site, San Francisco

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Massachusetts General Hospital

OTHER

NCT00339092 - Modified Directly Observed Therapy for Improving Antiretroviral Therapy Adherence in People With HIV | Biotech Hunter | Biotech Hunter